Phase I clinical trial to evaluate the safety, tolerability, pharmacokinetics and immunogenicity of recombinant human hyaluronidase injection (ZG096) in healthy Chinese subjects after single dose administration

Category Primary study
Registry of TrialsChinese Clinical Trial Register
Year 2025
This article has no abstract
Epistemonikos ID: 3597b7de5718fb429e83b1638761a7a74bf6dbbd
First added on: Apr 22, 2026